Appropriate Dosage and Usage of Spironolactone
For patients with heart failure, spironolactone should be initiated at 25 mg once daily or on alternate days, with a target dose of 25-50 mg once daily, requiring careful monitoring of potassium and renal function throughout treatment. 1
Indications and Dosing
Heart Failure
- Starting dose: 25 mg once daily (or 25 mg every other day in patients with eGFR 30-50 mL/min/1.73m²) 2
- Target dose: 25-50 mg once daily 1
- Maximum dose: 50 mg daily for heart failure 1, 2
Hypertension
- Starting dose: 25 mg daily 2
- Usual range: 25-100 mg daily 2
- For resistant hypertension: Low-dose spironolactone (25 mg) is highly effective as add-on therapy 3, 4
- Very low dose option: Even 12.5 mg daily can be effective in combination therapy for hypertension 5
Edema
- Starting dose: 25-100 mg daily 2
- Range: 25-200 mg daily 2
- For cirrhosis: Initiate in hospital setting and titrate slowly 2
Monitoring Protocol
Initial Monitoring
- Check baseline renal function and serum electrolytes before starting 1
- Recheck renal function and serum electrolytes at:
Long-term Monitoring
- Check at 1,4,8, and 12 weeks; then at 6,9, and 12 months; then every 6 months thereafter 1
- More frequent monitoring (every 5-7 days) until potassium values stabilize after dose changes 1
Dose Adjustment Based on Laboratory Values
Hyperkalemia Management
- If K+ rises to 5.5-6.0 mmol/L: Reduce dose to 25 mg on alternate days 1
- If K+ rises to >6.0 mmol/L: Stop spironolactone immediately 1
Renal Function
- If creatinine rises to >221 μmol/L (2.5 mg/dL): Reduce dose to 25 mg on alternate days 1
- If creatinine rises to >310 μmol/L (3.5 mg/dL): Stop spironolactone immediately 1
Special Considerations and Precautions
High-Risk Populations
- Elderly patients: Typically require lower doses (median ~20 mg/day) 6
- Renal dysfunction: For eGFR 30-50 mL/min/1.73m², start at 25 mg every other day 2
- Patients with potassium >4.5 mmol/L: Consider lower doses (median ~20 mg/day) 6
- CKD patients: Even in moderate CKD (GFR 25-50 mL/min), low-dose spironolactone can be effective for resistant hypertension with careful monitoring 7
Drug Interactions to Monitor
- ACE inhibitors and ARBs (increased risk of hyperkalemia) 1
- Other potassium-sparing diuretics (additive hyperkalemia risk) 1
- Potassium supplements (avoid concurrent use if possible) 1
- NSAIDs (increased risk of renal dysfunction and hyperkalemia) 1
Common Side Effects
- Hyperkalemia (most serious concern) 1
- Gynecomastia or breast discomfort in men (occurs in ~10% of male patients) 1, 4
- Worsening renal function 1
Important Clinical Pearls
- The triple combination of ACE inhibitors, ARBs, and spironolactone should generally be avoided due to high hyperkalemia risk 1
- Patients should temporarily stop spironolactone if they develop diarrhea or vomiting 1
- Advise patients to avoid high-potassium foods and "low salt" substitutes which often contain high potassium 1, 8
- In patients unable to tolerate target doses, a low-dose strategy (even 12.5 mg) is preferable to discontinuation 6, 5
- For heart failure patients, spironolactone has been shown to increase survival, reduce hospital admissions, and improve NYHA class 1
By following these dosing guidelines and monitoring protocols, spironolactone can be used effectively while minimizing the risk of adverse effects, particularly hyperkalemia and renal dysfunction.